Technical Analysis for ABMD - ABIOMED, Inc.
|Grade||Last Price||% Change||Price Change|
ABMD closed down 0.79 percent on Tuesday, June 19, 2018, on 1.11 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
|See historical ABMD trend table...|
|Date||Alert Name||Type||% Chg|
|Jun 19||Slingshot Bullish||Bullish Swing Setup||0.00%|
|Jun 19||NR7||Range Contraction||0.00%|
|Jun 19||Overbought Stochastic||Strength||0.00%|
|Jun 18||Spinning Top||Other||-0.79%|
|Jun 18||New 52 Week High||Strength||-0.79%|
|Jun 18||Upper Bollinger Band Walk||Strength||-0.79%|
|Jun 18||Overbought Stochastic||Strength||-0.79%|
|Jun 15||New 52 Week Closing High||Bullish||-0.89%|
|Jun 15||New 52 Week High||Strength||-0.89%|
|Jun 15||Upper Bollinger Band Walk||Strength||-0.89%|
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
ABIOMED, Inc. provides medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. Its products consist of Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; Impella CP, a micro heart pump; and Impella 5.0 catheter and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite. The company also manufactures and sells the Impella RP, a percutaneous catheter-based axial flow pump; and AB5000 circulatory support system and the BVS 5000 biventricular support system for temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis. In addition, it offers Symphony, a synchronized minimally invasive implantable cardiac assist device designed to treat chronic patients with moderate heart failure by improving patient hemodynamics; and AbioCor implantable replacement heart. The company sells its products through direct sales and clinical support personnel in the United States, Canada, Germany, France, the United Kingdom, and internationally. ABIOMED, Inc. was founded in 1981 and is headquartered in Danvers, Massachusetts.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more ABMD news...
|52 Week High||446.81|
|52 Week Low||139.49|
|200-Day Moving Average||250.9244|
|50-Day Moving Average||361.678|
|20-Day Moving Average||410.3145|
|10-Day Moving Average||427.481|
|Average True Range||12.0288|
|Chandelier Exit (Long, 3 ATRs )||410.7236|
|Chandelier Exit (Short, 3 ATRs )||411.0864|
|Upper Bollinger Band||451.5645|
|Lower Bollinger Band||369.0645|
|Percent B (%b)||0.86|
|MACD Signal Line||21.3996|
|Market Cap||19.4 Billion|
|Num Shares||44.1 Million|
|Price-to-Earnings (P/E) Ratio||257.10|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||454.12|
|Resistance 3 (R3)||453.19||447.43||451.70|
|Resistance 2 (R2)||447.43||443.75||447.90||450.90|
|Resistance 1 (R1)||443.54||441.47||445.49||444.47||450.09|
|Support 1 (S1)||433.89||434.10||435.84||434.82||429.19|
|Support 2 (S2)||428.13||431.82||428.60||428.38|
|Support 3 (S3)||424.24||428.13||427.58|
|Support 4 (S4)||425.17|